Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Orthopediatrics (KIDS) over the last 10 years, with Q3 2025 value amounting to -$191000.0.

  • Orthopediatrics' Other Working Capital Changes fell 11500.39% to -$191000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $185000.0, marking a year-over-year decrease of 9612.4%. This contributed to the annual value of $1.6 million for FY2024, which is 6629.24% down from last year.
  • Orthopediatrics' Other Working Capital Changes amounted to -$191000.0 in Q3 2025, which was down 11500.39% from $308000.0 recorded in Q2 2025.
  • Orthopediatrics' 5-year Other Working Capital Changes high stood at $1.7 million for Q4 2023, and its period low was -$1.5 million during Q4 2024.
  • For the 5-year period, Orthopediatrics' Other Working Capital Changes averaged around $419368.4, with its median value being $367000.0 (2022).
  • Data for Orthopediatrics' Other Working Capital Changes shows a peak YoY increase of 95983.61% (in 2021) and a maximum YoY decrease of 136428.57% (in 2021) over the last 5 years.
  • Over the past 5 years, Orthopediatrics' Other Working Capital Changes (Quarter) stood at $144000.0 in 2021, then soared by 154.86% to $367000.0 in 2022, then surged by 369.21% to $1.7 million in 2023, then plummeted by 186.53% to -$1.5 million in 2024, then skyrocketed by 87.18% to -$191000.0 in 2025.
  • Its last three reported values are -$191000.0 in Q3 2025, $308000.0 for Q2 2025, and $1.6 million during Q1 2025.